Webcasts & Presentations
Upcoming Events
| Date | Event Details | Remind me |
|---|---|---|
|
June 7, 2022 at 11:30 AM EDT
|
Lilly Diabetes & Obesity Update at ADA
|
|
|
August 4, 2022 at 9:00 AM EDT
|
Q2 2022 Earnings Call
|
|
|
November 1, 2022 at 9:00 AM EDT
|
Q3 2022 Earnings Call
|
|
|
December 13, 2022 at 9:00 AM EST
|
2023 Guidance Call
|
Archived Events
| Date | Event Details |
|---|---|
|
May 24, 2022 at 8:30 AM EDT
|
UBS 2022 Global Healthcare Conference
Speaker: Mike Mason, Senior Vice President and President, Lilly Diabetes
|
|
May 10, 2022 at 7:40 PM EDT
|
Bank of America Securities 2022 Healthcare Conference
Speaker: Dr. Dan Skovronsky, Senior Vice President and Chief Scientific Officer
|
|
April 28, 2022 at 9:00 AM EDT
|
Q1 2022 Earnings Call
Q1 2022 Lilly Presentation 11.8 MB
Q1 2022 Lilly Press Release 266.7 KB
Q1 2022 Financial Workbook 105.8 KB
|
|
March 15, 2022 at 10:15 AM EDT
|
Barclays 2022 Global Healthcare Conference
Speaker: Patrik Jonsson, Senior Vice President, President of Lilly Immunology and Lilly USA, and Chief Customer Officer |
|
March 8, 2022 at 10:30 AM EST
|
Cowen Health Care Conference
Speaker: Anat Ashkenazi, Senior Vice President and Chief Financial Officer
|
|
February 9, 2022 at 12:00 PM EST
|
Guggenheim Oncology Conference
Speakers: Jake Van Naarden, CEO of Loxo Oncology at Lilly and President of Lilly Oncology and David Hyman, Chief Medical Officer, Lilly Oncology
|
|
February 3, 2022 at 9:00 AM EST
|
Q4 2021 Earnings Call
Q4 2021 Lilly Press Release 268.6 KB
Q4 2021 Financial Workbook 136.7 KB
|
|
January 11, 2022 at 4:30 PM EST
|
40th Annual JP Morgan Healthcare Conference
Speaker: Dave Ricks, Chair and Chief Executive Officer
|
|
December 15, 2021 at 9:00 AM EST
|
Investment Community Meeting
|
|
November 30, 2021 at 12:10 PM EST
|
4th Annual Evercore ISI HealthCONx Conference
Speaker: Dr. Dan Skovronsky, Senior Vice President and Chief Scientific Officer
|
|
November 18, 2021 at 10:30 AM EST
|
Wolfe Research Virtual Healthcare Conference
Speakers: Jake Van Naarden, CEO of Loxo Oncology at Lilly and President of Lilly Oncology, David Hyman, Chief Medical Officer, Lilly Oncology and Mark Mintun, Senior Vice President, R&D – Neuroscience and President, Avid Radiopharmaceuticals
|
|
November 4, 2021 at 12:30 PM EDT
|
Bernstein’s 2nd Annual Operational Decisions Conference
Speakers: Jake Van Naarden, CEO of Loxo Oncology at Lilly and President of Lilly Oncology, Mark Mintun, Senior Vice President, R&D – Neuroscience and President, Avid Radiopharmaceuticals and Jamie Croaning, Global Development Leader – Tirzepatide
|
|
October 26, 2021 at 9:00 AM EDT
|
Q3 2021 Earnings Call
Q3 2021 Lilly Press Release 247.8 KB
Q3 2021 Financial Workbook 126.6 KB
|
|
September 28, 2021 at 1:20 PM EDT
|
2021 Cantor Virtual Global Healthcare Conference
Speaker: Patrik Jonsson, Senior Vice President, President of Lilly Immunology and Lilly USA, and Chief Customer Officer
|
|
September 14, 2021 at 1:15 PM EDT
|
Morgan Stanley 19th Annual Global Healthcare Conference
Speaker: Mike Mason, Senior Vice President and President, Lilly Diabetes
|
|
September 9, 2021 at 9:45 AM EDT
|
Citi’s 16th Annual BioPharma Virtual Conference
Speaker: Anat Ashkenazi, Senior Vice President and Chief Financial Officer
|
|
August 3, 2021 at 9:00 AM EDT
|
Q2 2021 Earnings Call
Q2 2021 Earnings Presentation 11.1 MB
Q2 2021 Lilly Press Release 247.9 KB
Q2 2021 Financial Workbook 123.8 KB
|
|
July 1, 2021 at 10:00 AM EDT
|
Lilly Diabetes Update at ADA
|
|
June 18, 2021 at 11:00 AM EDT
|
Guggenheim Biopharma Strategy Series | Biopharma’s Next Decade: Views from the Top on Global Strategy and Innovation
Speaker: Dr. Dan Skovronsky, Senior Vice President and Chief Scientific Officer
|
